NCT03626168

Brief Summary

Watermelon is the only food with a unique combination of amino acids and antioxidants that may reduce artery stiffness. However, only 27% of older adults meet the daily recommendation for fruit intake. Because it tastes good and is convenient and easy to consume, watermelon juice is an innovative and impactful intervention to help elders easily meet recommendations for fruit servings. If effective, this intervention would be a simple, inexpensive way to combat cardiovascular diseases (CVD). Results will advance science by providing a better understanding whether four-week consumption of 100% watermelon juice may impact measures of vascular health and inflammation in postmenopausal women.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2016

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 10, 2018

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

May 17, 2022

Completed
Last Updated

May 17, 2022

Status Verified

May 1, 2022

Enrollment Period

2.2 years

First QC Date

July 24, 2018

Results QC Date

September 9, 2021

Last Update Submit

May 16, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change From Baseline in Serum Levels of Lycopene at 4 Weeks

    Lycopene determined by ultra high performance liquid chromatography with photodiode array detector (UPLC-PDA).

    Baseline and 4 Weeks

  • Change in Vascular Endothelial Function at 4 Weeks

    Determined by brachial artery flow-mediated dilation (FMD). FMD uses ultrasound technology to quantify changes in brachial artery diameter in response to hyperemia. A blood pressure cuff was placed distal to the brachial artery of the right arm with the participant supine and rested. Pre-inflation diameter was recorded for one minute, and the cuff was inflated to 50 mmHg above resting SBP for five minutes. Then, images were recorded for 120 seconds after cuff deflation. Peak diameter was determined as an average of the five highest measurements over five seconds post-deflation. FMD was expressed as the percentage increase in peak diameter.

    Baseline and 4 weeks

  • Change in Arterial Stiffness at 4 Weeks

    Determined by pulse wave velocity (PWV). A cuff-based system was used to measure brachial oscillometric pressure waveforms and generate central pressure curves by propriety algorithms. PWV was quantified as the rate at which a pulse wave moves down a vessel.

    Baseline and 4 weeks

Study Arms (2)

Consumption of 100% watermelon juice

ACTIVE COMPARATOR

Consumption of two 12-ounce doses of pasteurized 100% watermelon juice for a four-week period

Dietary Supplement: 100% watermelon juice

Consumption of a placebo beverage

PLACEBO COMPARATOR

Consumption of a placebo beverage with comparable sugar content, pH, taste, texture, and color for a four-week period

Other: Placebo beverage

Interventions

100% watermelon juiceDIETARY_SUPPLEMENT

Participants drank two 12-ounce servings of 100% watermelon juice per day for a four-week period.

Consumption of 100% watermelon juice

Participants drank two 12-ounce servings of a placebo beverage per day for a four-week period.

Consumption of a placebo beverage

Eligibility Criteria

Age55 Years - 69 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ambulatory
  • Female
  • Age 55-69 years
  • Body mass index 18.5 - 29.9 kg/m2 (non-obese)

You may not qualify if:

  • Food allergy to watermelon
  • History of hypotension, chronic hypertension, chronic kidney disease, diabetes, previous cardiac events or procedures, phenylketonuria
  • Smoking or other tobacco use
  • Use of anticoagulant medications, cholesterol-lowering medications, blood-pressure medications, vasodilatory dietary supplements (garlic, fish oil), or dietary supplements containing lycopene, ascorbic acid, L-glutamine, L-arginine, or L-citrulline
  • Weight change \> 10% in the previous year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Ellis AC, Dudenbostel T, Locher JL, Crowe-White K. Modulating Oxidative Stress and Inflammation in Elders: The MOXIE Study. J Nutr Gerontol Geriatr. 2016 Oct-Dec;35(4):219-242. doi: 10.1080/21551197.2016.1250693.

    PMID: 27897608BACKGROUND
  • Ellis AC, Mehta T, Nagabooshanam VA, Dudenbostel T, Locher JL, Crowe-White KM. Daily 100% watermelon juice consumption and vascular function among postmenopausal women: A randomized controlled trial. Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2959-2968. doi: 10.1016/j.numecd.2021.06.022. Epub 2021 Jul 7.

  • Crowe-White KM, Voruganti VS, Talevi V, Dudenbostel T, Nagabooshanam VA, Locher JL, Ellis AC. Variation of Serum Lycopene in Response to 100% Watermelon Juice: An Exploratory Analysis of Genetic Variants in a Randomized Controlled Crossover Study. Curr Dev Nutr. 2020 Jun 17;4(7):nzaa102. doi: 10.1093/cdn/nzaa102. eCollection 2020 Jul.

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Amy Ellis, principal investigator
Organization
The University of Alabama

Study Officials

  • Amy C Ellis, PhD, RD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Kristi Crowe-White, PhD, RD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
In this crossover design, the participants principal investigators, and outcomes assessors were blinded as to which treatment (100% watermelon juice or placebo) was consumed at each time.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: In a double-blind crossover design, women ages 55-69 years were randomized to two 12-ounce servings of 100% watermelon juice per day or an isocaloric placebo for four weeks each with a 2-week washout period in between.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 24, 2018

First Posted

August 10, 2018

Study Start

February 16, 2016

Primary Completion

May 12, 2018

Study Completion

May 12, 2018

Last Updated

May 17, 2022

Results First Posted

May 17, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share